BC3402
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BC3402, covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma [Phase 1, Phase 2]